Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inex gene therapy reduces metastatic tumors in preclinical trials

June 3, 1998

NeXstar granted option to license vaccine technology

June 3, 1998

GlycoDesign seeking licensees for its carbohydrate-processing inhibitor GD0039

June 3, 1998

Vinflunine, a vinca alkaloid with more potent activity than vinorelbine in preclinical models

June 2, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

Liarozole, a RAMBA with clinical efficacy in treating prostate cancer

June 2, 1998

Sparta receives FDA approval for phase II/III trials of Spartaject busulfan

June 2, 1998

Agents for tumors and tumor metastasis synthesized at Ishihara Sangyo

June 1, 1998

Protein tyrosine or serine/threonine kinase inhibitors in development at Novartis

June 1, 1998

Imutech and Harvard Medical School join forces for clotrimazole development

June 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...